XTL Biopharmaceuticals Ltd.

XTLBNASDAQ Capital Market·USD·Closed

XTLBNASDAQ·USD·Closed

$2.82

−1.05%

$2.82

−$0.03 (1.05%)

52W Range

10thpctl

Volume

0.01×avg

Mkt Cap

6.67MUSD

P/E

-0.8TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

10thpctl

Volume

0.01×avg

Market Cap

6.67MUSD

P/E Ratio

-0.8TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-11253.3%

Financially safe

Stretched

Debt / equity-1.06×

Interest coverage-241.1×

Current ratio0.40×